Quarterly report pursuant to Section 13 or 15(d)

Other current assets

v3.20.2
Other current assets
9 Months Ended
Sep. 30, 2020
Other current assets  
Other current assets

Note 7 — Other current assets

Other current assets consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

​

    

2020

    

2019

Corporate tax receivable

 

$

13,921

 

$

19,284

Prepayments

 

​

7,754

 

​

8,395

Clinical materials

 

​

2,488

 

​

1,459

Other current assets

 

​

2,662

 

​

1,809

​

​

$

26,825

​

$

30,947

​